ConductScience.org, home

Paper28296562

Immunomodulatory Yersinia outer proteins (Yops)-useful tools for bacteria and humans alike.

Grabowski B and 2 others. Virulence, 2017. Cited by 38 papers, by iCite.

Cite this record

ConductScience Library. Immunomodulatory Yersinia outer proteins (Yops)-useful tools for bacteria and humans alike. Papers, record 28296562. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28296562

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immunomodulatory Yersinia outer proteins (Yops)-useful tools for bacteria and humans alike.
PubMed
Journal
Virulence
PubMed
Year
2017
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
38
iCite
Relative citation ratio, by iCite
1.52
iCite
Revised in PubMed
2018-11-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Grabowski BBenjamin
2Schmidt MAM Alexander
3Rüter CChristian

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bacterial Outer Membrane ProteinsMajor topic
YersiniaMajor topic
Yersinia InfectionsMajor topic
Animals
Humans
Type III Secretion Systems

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in28636422Usurping bacterial virulence factors as self-delivery vehicles for therapeutic use.https://conductscience.org/library/papers/28636422

Source PubMed

Download CSV of comments and corrections

References243

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117608743YopJ targets TRAF proteins to inhibit TLR-mediated NF-kappaB, MAPK and IRF3 signal transduction.Cell Microbiol2007https://conductscience.org/library/papers/17608743PubMed
224261744'Drugs from bugs': bacterial effector proteins as promising biological (immune-) therapeutics.FEMS Microbiol Lett2014https://conductscience.org/library/papers/24261744PubMed
37803389The Cys(X)5Arg catalytic motif in phosphoester hydrolysis.Biochemistry1994https://conductscience.org/library/papers/7803389PubMed
42166336Protein tyrosine phosphatase activity of an essential virulence determinant in Yersinia.Science1990https://conductscience.org/library/papers/2166336PubMed
57628694Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway.Genes Dev1995https://conductscience.org/library/papers/7628694PubMed
611801671Yersinia enterocolitica evasion of the host innate immune response by V antigen-induced IL-10 production of macrophages is abrogated in IL-10-deficient mice.J Immunol2002https://conductscience.org/library/papers/11801671PubMed
714694194The crystal structure of Pseudomonas avirulence protein AvrPphB: a papain-like fold with a distinct substrate-binding site.Proc Natl Acad Sci U S A2004https://conductscience.org/library/papers/14694194PubMed
82311122Multiple beta 1 chain integrins are receptors for invasin, a protein that promotes bacterial penetration into mammalian cells.Cell1990https://conductscience.org/library/papers/2311122PubMed
99680215The Yersinia Yops inhibit invasion of Listeria, Shigella and Edwardsiella but not Salmonella into epithelial cells.Mol Microbiol1998https://conductscience.org/library/papers/9680215PubMed
1016041032LcrV plague vaccine with altered immunomodulatory properties.Infect Immun2005https://conductscience.org/library/papers/16041032PubMed
1125165815The GAP activity of type III effector YopE triggers killing of Yersinia in macrophages.PLoS Pathog2014https://conductscience.org/library/papers/25165815PubMed
1218406372Crosstalk of signalling processes of innate immunity with Yersinia Yop effector functions.Immunobiology2008https://conductscience.org/library/papers/18406372PubMed
1315981459Regulation of phagocytosis by Rho GTPases.Curr Top Microbiol Immunol2005https://conductscience.org/library/papers/15981459PubMed
1421220342Translocation of surface-localized effectors in type III secretion.Proc Natl Acad Sci U S A2011https://conductscience.org/library/papers/21220342PubMed
1511069923Identification of residues in the N-terminal domain of the Yersinia tyrosine phosphatase that are critical for substrate recognition.J Biol Chem2001https://conductscience.org/library/papers/11069923PubMed
1617606597Serogroup-related escape of Yersinia enterocolitica YopE from degradation by the ubiquitin-proteasome pathway.Infect Immun2007https://conductscience.org/library/papers/17606597PubMed
1717697254Function and molecular architecture of the Yersinia injectisome tip complex.Mol Microbiol2007https://conductscience.org/library/papers/17697254PubMed
1816919435Integrin-regulated FAK-Src signaling in normal and cancer cells.Curr Opin Cell Biol2006https://conductscience.org/library/papers/16919435PubMed
1912360191The Yersinia Ysc-Yop 'type III' weaponry.Nat Rev Mol Cell Biol2002https://conductscience.org/library/papers/12360191PubMed
2026981193Yersinia type III effectors perturb host innate immune responses.World J Biol Chem2016https://conductscience.org/library/papers/26981193PubMed

See all 243 referencesDownload CSV of references

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.

PMIDTitleJournalYearIn PapersSource
42576894Anti-infective compounds for Yersinia.Sustain Microbiol2026https://conductscience.org/library/papers/42576894PubMed
42123617Targeting Undruggable Protein Interactions with DNA Aptamers: Inhibition of the Interaction Between Yersinia Outer Protein M and Human DEAD-Box Helicase 3.Int J Mol Sci2026https://conductscience.org/library/papers/42123617PubMed
42094561The Shigella E3 ubiquitin ligase IpaH7.8 reprograms host kinase signaling to suppress NOX2-dependent oxidative burst responses in human monocytes.bioRxiv2026https://conductscience.org/library/papers/42094561PubMed
41708621A bacterial YopJ-family acetyltransferase suppresses host immune response by Nε-acetylation of JAK1.Nat Commun2026https://conductscience.org/library/papers/41708621PubMed
40806347A Narrative Review on the Multifaceted Roles of Galectins in Host-Pathogen Interactions During Helicobacter pylori Infection.Int J Mol Sci2025https://conductscience.org/library/papers/40806347PubMed
40240908Yersinia pestis Actively Inhibits the Production of Extracellular Vesicles by Human Neutrophils.J Extracell Vesicles2025https://conductscience.org/library/papers/40240908PubMed
39423229Distinct mechanisms of type 3 secretion system recognition control LTB4 synthesis in neutrophils and macrophages.PLoS Pathog2024https://conductscience.org/library/papers/39423229PubMed
39005373Distinct Mechanisms of Type 3 Secretion System Recognition Control LTB4 Synthesis in Neutrophils versus Macrophages.bioRxiv2024https://conductscience.org/library/papers/39005373PubMed
38835755Sex differences in immune protection in mice conferred by heterologous vaccines for pneumonic plague.Front Immunol2024https://conductscience.org/library/papers/38835755PubMed
38271464Type 3 secretion system induced leukotriene B4 synthesis by leukocytes is actively inhibited by Yersinia pestis to evade early immune recognition.PLoS Pathog2024https://conductscience.org/library/papers/38271464PubMed
37621095Macrophage innate immune responses delineate between defective translocon assemblies produced by Yersinia pseudotuberculosis YopD mutants.Virulence2023https://conductscience.org/library/papers/37621095PubMed
36968108Yersinia enterocolitica in Crohn's disease.Front Cell Infect Microbiol2023https://conductscience.org/library/papers/36968108PubMed
36617629Immune evasion and persistence in enteric bacterial pathogens.Gut Microbes2023https://conductscience.org/library/papers/36617629PubMed
35255676Yersinia pestis antibiotic resistance: a systematic review.Osong Public Health Res Perspect2022https://conductscience.org/library/papers/35255676PubMed
35043994Type III secretion by Yersinia pseudotuberculosis is reliant upon an authentic N-terminal YscX secretor domain.Mol Microbiol2022https://conductscience.org/library/papers/35043994PubMed
34827634Galectin-1 Cooperates with Yersinia Outer Protein (Yop) P to Thwart Protective Immunity by Repressing Nitric Oxide Production.Biomolecules2021https://conductscience.org/library/papers/34827634PubMed
34154409LcrQ Coordinates with the YopD-LcrH Complex To Repress lcrF Expression and Control Type III Secretion by Yersinia pseudotuberculosis.mBio2021https://conductscience.org/library/papers/34154409PubMed
34142207Plague vaccines: new developments in an ongoing search.Appl Microbiol Biotechnol2021https://conductscience.org/library/papers/34142207PubMed
33257532Modification of the Pulmonary MyD88 Inflammatory Response Underlies the Role of the Yersinia pestis Pigmentation Locus in Primary Pneumonic Plague.Infect Immun2021https://conductscience.org/library/papers/33257532PubMed
32973776Utilization of Galectins by Pathogens for Infection.Front Immunol2020https://conductscience.org/library/papers/32973776PubMed

See all 27 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28296562

GET https://conductscience.org/api/papers/v1/28296562/references?page=2